NUF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.742200E-01
Normal-vs-Stage2
2.356600E-01
Normal-vs-Stage3
5.533600E-01
Normal-vs-Stage4
4.638800E-01
Stage1-vs-Stage2
3.760600E-01
Stage1-vs-Stage3
9.506200E-01
Stage1-vs-Stage4
7.254000E-01
Stage2-vs-Stage3
5.098400E-01
Stage2-vs-Stage4
7.650400E-01
Stage3-vs-Stage4
7.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.760600E-01
Normal-vs-AfricanAmerican
2.990800E-01
Normal-vs-Asian
2.752000E-01
Caucasian-vs-AfricanAmerican
7.714400E-01
Caucasian-vs-Asian
5.847000E-01
AfricanAmerican-vs-Asian
5.805800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.786000E-01
Normal-vs-Female
2.668000E-01
Male-vs-Female
7.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.917200E-01
Normal-vs-Age(41-60Yrs)
2.741800E-01
Normal-vs-Age(61-80Yrs)
2.659400E-01
Normal-vs-Age(81-100Yrs)
2.247400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.162200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.119790E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.599600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.169600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.566800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.987800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.231200E-01
Normal-vs-Daily Drinker
3.779400E-01
Normal-vs-Weekly Drinker
2.680600E-01
Normal-vs-Occasional Drinker
1.612410E-01
Normal-vs-Social Drinker
3.290400E-01
Non Drinker-vs-Daily Drinker
4.224400E-01
Non Drinker-vs-Weekly Drinker
8.868800E-01
Non Drinker-vs-Occasional Drinker
5.706400E-01
Non Drinker-vs-Social Drinker
9.162000E-01
Daily Drinker-vs-Weekly Drinker
3.693000E-01
Daily Drinker-vs-Occasional Drinker
1.508790E-01
Daily Drinker-vs-Social Drinker
5.310200E-01
Weekly Drinker-vs-Occasional Drinker
7.123200E-01
Weekly Drinker-vs-Social Drinker
8.206400E-01
Occasional Drinker-vs-Social Drinker
5.337400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.134200E-01
Normal-vs-Grade 2
8.883400E-01
Normal-vs-Grade 3
8.976000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.500400E-03
Grade 1-vs-Grade 3
1.542640E-03
Grade 1-vs-Grade 4
7.134200E-01
Grade 2-vs-Grade 3
2.352400E-01
Grade 2-vs-Grade 4
8.883400E-01
Grade 3-vs-Grade 4
8.976000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.437200E-01
Normal-vs-NonDiabetic
2.343200E-01
Diabetic-vs-NonDiabetic
2.131000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.884040E-01
Normal-vs-NoPancreatitis
3.027000E-01
Pancreatitis-vs-NoPancreatitis
6.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.825170E-01
Normal-vs-N1
2.896400E-01
N0-vs-N1
3.374800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.271900E-02
Normal-vs-TP53-NonMutant
3.459800E-01
TP53-Mutant-vs-TP53-NonMutant
4.03589999975473E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
